Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 203

1.

An evaluation of knowledge, attitude and practice of Indian pharmacists towards adverse drug reaction reporting: A pilot study.

Ahmad A, Patel I, Balkrishnan R, Mohanta GP, Manna PK.

Perspect Clin Res. 2013 Oct;4(4):204-10. doi: 10.4103/2229-3485.120168.

2.

A questionnaire study on the knowledge, attitude, and the practice of pharmacovigilance among the healthcare professionals in a teaching hospital in South India.

Gupta SK, Nayak RP, Shivaranjani R, Vidyarthi SK.

Perspect Clin Res. 2015 Jan-Mar;6(1):45-52. doi: 10.4103/2229-3485.148816.

3.

Medication safety knowledge, attitudes and practices among community pharmacists in Lebanon.

Hajj A, Hallit S, Ramia E, Salameh P; Order of Pharmacists Scientific Committee – Medication Safety Subcommittee.

Curr Med Res Opin. 2017 Aug 30:1-8. doi: 10.1080/03007995.2017.1361916. [Epub ahead of print]

PMID:
28758813
4.

Knowledge, attitudes and practice of nurse regarding adverse drug reaction reporting.

Hanafi S, Torkamandi H, Hayatshahi A, Gholami K, Javadi M.

Iran J Nurs Midwifery Res. 2012 Jan;17(1):21-5.

5.

The knowledge and attitude of the Turkish community pharmacists toward pharmacovigilance in the Kadikoy district of Istanbul.

Toklu HZ, Uysal MK.

Pharm World Sci. 2008 Oct;30(5):556-62. doi: 10.1007/s11096-008-9209-4. Epub 2008 Mar 19.

PMID:
18350373
6.

Knowledge, attitude and practice of General Practitioners towards adverse drug reaction reporting in South of Iran, Shiraz (Pharmacoepidemiology report).

Peymani P, Tabrizi R, Afifi S, Namazi S, Heydari ST, Shirazi MK, Nouraei H, Sadeghi E, Lankarani KB, Maharlouei N.

Int J Risk Saf Med. 2016 Mar 16;28(1):25-31. doi: 10.3233/JRS-160670.

PMID:
27176754
7.

A cross sectional pilot study on assessing the knowledge, attitude and behavior of community pharmacists to adverse drug reaction related aspects in the Sultanate of Oman.

Jose J, Jimmy B, Al-Ghailani AS, Al Majali MA.

Saudi Pharm J. 2014 Apr;22(2):163-9. doi: 10.1016/j.jsps.2013.07.006. Epub 2013 Aug 8.

8.

Pharmacovigilance and adverse drug reaction reporting: a perspective of community pharmacists and pharmacy technicians in Sana'a, Yemen.

Al-Worafi YM, Kassab YW, Alseragi WM, Almutairi MS, Ahmed A, Ming LC, Alkhoshaiban AS, Hadi MA.

Ther Clin Risk Manag. 2017 Sep 7;13:1175-1181. doi: 10.2147/TCRM.S140674. eCollection 2017.

PMID:
28924350
9.

Hospital pharmacists' knowledge and opinions regarding adverse drug reaction reporting in Northern China.

Su C, Ji H, Su Y.

Pharmacoepidemiol Drug Saf. 2010 Mar;19(3):217-22. doi: 10.1002/pds.1792.

PMID:
20033911
10.

Adverse drug reactions reporting: pharmacists' knowledge, attitude and practice in Shiraz, Iran.

Afifi S, Maharloui N, Peymani P, Namazi S, Gharaei AG, Jahani P, Lankarani KB.

Int J Risk Saf Med. 2014;26(3):139-45. doi: 10.3233/JRS-140620.

PMID:
25214159
11.

Knowledge, attitudes, and perceptions of pharmacists to adverse drug reaction reporting in Iran.

Vessal G, Mardani Z, Mollai M.

Pharm World Sci. 2009 Apr;31(2):183-7. doi: 10.1007/s11096-008-9276-6. Epub 2008 Dec 31.

PMID:
19116770
12.

Evaluation of awareness about pharmacovigilance and adverse drug reaction monitoring in resident doctors of a tertiary care teaching hospital.

Pimpalkhute SA, Jaiswal KM, Sontakke SD, Bajait CS, Gaikwad A.

Indian J Med Sci. 2012 Mar-Apr;66(3-4):55-61. doi: 10.4103/0019-5359.110902.

PMID:
23603621
13.

Knowledge, perception and practice of pharmacovigilance among community pharmacists in South India.

Prakasam A, Nidamanuri A, Kumar S.

Pharm Pract (Granada). 2012 Oct;10(4):222-6. Epub 2012 Dec 31.

14.

Perception of pharmacovigilance among doctors in a tertiary care hospital: influence of an interventional lecture.

Sanghavi DR, Dhande PP, Pandit VA.

Int J Risk Saf Med. 2013;25(4):197-204. doi: 10.3233/JRS-130598.

PMID:
24305558
15.

Pattern of adverse drug reactions reported by the community pharmacists in Nepal.

Palaian S, Ibrahim MI, Mishra P.

Pharm Pract (Granada). 2010 Jul;8(3):201-7. Epub 2010 Mar 15.

16.

Knowledge and attitude of health-care professionals in hospitals towards pharmacovigilance in Saudi Arabia.

Alshammari TM, Alamri KK, Ghawa YA, Alohali NF, Abualkol SA, Aljadhey HS.

Int J Clin Pharm. 2015 Dec;37(6):1104-10. doi: 10.1007/s11096-015-0165-5. Epub 2015 Jul 28.

PMID:
26216270
17.

Under-reporting of adverse drug reactions: a challenge for pharmacovigilance in India.

Tandon VR, Mahajan V, Khajuria V, Gillani Z.

Indian J Pharmacol. 2015 Jan-Feb;47(1):65-71. doi: 10.4103/0253-7613.150344.

18.

Community pharmacists' knowledge, behaviors and experiences about adverse drug reaction reporting in Saudi Arabia.

Mahmoud MA, Alswaida Y, Alshammari T, Khan TM, Alrasheedy A, Hassali MA, Aljadhey H.

Saudi Pharm J. 2014 Nov;22(5):411-8. doi: 10.1016/j.jsps.2013.07.005. Epub 2013 Aug 21.

19.

Physicians' knowledge and attitude towards adverse event reporting system and result to intervention--randomized nested trial among Bulgarian physicians.

Stoynova V, Getov IN, Naseva EK, Lebanova HV, Grigorov EE.

Med Glas (Zenica). 2013 Aug;10(2):365-72.

PMID:
23892860
20.

Supplemental Content

Support Center